The Medical Oncology Department at Mardaleishvili Medical Centre is the largest medical cancer treatment unit within one of Georgia’s most multi-profile oncological hospitals. The department provides chemotherapy, immunotherapy, targeted therapy, and hormonal therapy for solid tumors and hematological diseases—including Non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, and multiple myeloma. The unit is headed by Nia Sharikadze, an oncologist and onco-hematologist with 30 years of clinical experience. She is a member of ESMO, ASCO, and ESO and has participated in over 24 international clinical trials. All treatment protocols comply with ESMO and U.S. National Comprehensive Cancer Network (NCCN) guidelines.

• Address: Charkviani St., Tbilisi, 0186
• Registration: +995 32 2430100 | service@mmc.ge
• Head of Department: Nia Sharikadze, M.D.

Nia Sharikadze graduated from Tbilisi State Medical University in 1990 and received her degree in oncology and hematology in 2002. She has over 30 years of experience in clinical oncology, has published 12 scientific papers, and participated in more than 24 international clinical trials. Dr. Sharikadze is an expert oncologist for the Ministry of Health of Georgia and the Solidarity Fund. Before joining the Mardaleishvili team in 2018, she headed the oncology department at “MediClub Georgia” from 2009 to 2018. She has contributed significantly to the development of Georgia’s national oncological treatment guidelines, including protocols for cervical and breast cancer under the City Cancer Challenge initiative.

Key Services:

• Chemotherapy: Treatment for all cancer localizations using the latest ESMO and NCCN protocols. Cases are reviewed by a multidisciplinary board (oncologist, surgeon, radiologist, radiation therapist).
• Immunotherapy: Use of immune checkpoint inhibitors and other agents to help the immune system destroy cancer cells, based on molecular and genomic analysis.
• Targeted Therapy: Targeted at specific molecular markers of cancer cells, making treatment more precise than standard chemotherapy.
• Hormonal Therapy: Used for hormone-dependent tumors, particularly breast and prostate cancer.
• Onco-hematology: Specialized treatment for Non-Hodgkin’s lymphoma, Hodgkin’s lymphoma, and multiple myeloma.
• Clinical Trials: Access to the latest drugs through international clinical trials free of charge.
• Day Inpatient Care: Allows patients to receive treatment and return home the same day.
• State Funding: Chemotherapy is funded within the framework of state oncology programs, covering both drug costs and administration.